相似文献
1
Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.
Br J Cancer. 1984 Jun;49(6):717-22. doi: 10.1038/bjc.1984.113.
2
Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.
J Clin Endocrinol Metab. 1992 Sep;75(3):865-70. doi: 10.1210/jcem.75.3.1517379.
3
Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase.
Cancer Res. 1983 Aug;43(8):3583-5.
4
Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle.
Eur J Cancer Clin Oncol. 1983 May;19(5):615-21. doi: 10.1016/0277-5379(83)90177-3.
5
6
Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
Breast Cancer Res Treat. 1986;7 Suppl:S83-90.
7
Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin.
J Cancer Res Clin Oncol. 1996;122(10):603-12. doi: 10.1007/BF01221192.
8
Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.
Cancer Res. 1989 Mar 15;49(6):1515-20.
9
Cell cycle kinetic effects of tamoxifen on human breast cancer cells. Flow cytometric analyses of DNA content, BrdU labeling, Ki-67, PCNA, and statin expression.
Ann N Y Acad Sci. 1993 Nov 30;698:174-81. doi: 10.1111/j.1749-6632.1993.tb17206.x.
10
Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling.
Anticancer Res. 1994 Sep-Oct;14(5A):2025-32.
引用本文的文献
1
A reappraisal of cell cycle phase enrichment in synchronized estrogen receptor-positive cell models derived from breast adenocarcinomas.
Sci Rep. 2025 Feb 18;15(1):5949. doi: 10.1038/s41598-025-90456-8.
2
Combinatorial treatments of tamoxifen and SM6Met, an extract from Vogel, are superior to either treatment alone in MCF-7 cells.
Front Pharmacol. 2022 Sep 22;13:1017690. doi: 10.3389/fphar.2022.1017690. eCollection 2022.
3
Effects of neoadjuvant therapies on genetic regulation of targeted pathways in ER+ primary ductal breast carcinoma: A meta-analysis of microarray datasets.
Saudi Pharm J. 2021 Jul;29(7):656-669. doi: 10.1016/j.jsps.2021.04.027. Epub 2021 Apr 30.
4
Moonlighting Proteins and Cardiopathy in the Spatial Response of MCF-7 Breast Cancer Cells to Tamoxifen.
Proteomics Clin Appl. 2019 Sep;13(5):e1900029. doi: 10.1002/prca.201900029. Epub 2019 Jul 25.
5
Changes in DNA Damage Repair Gene Expression and Cell Cycle Gene Expression Do Not Explain Radioresistance in Tamoxifen-Resistant Breast Cancer.
Oncol Res. 2020 Feb 7;28(1):33-40. doi: 10.3727/096504019X15555794826018. Epub 2019 Apr 18.
6
Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells.
Mol Cell Endocrinol. 2017 Mar 15;444:38-47. doi: 10.1016/j.mce.2017.01.044. Epub 2017 Jan 28.
7
Altered radiation responses of breast cancer cells resistant to hormonal therapy.
Oncotarget. 2015 Jan 30;6(3):1678-94. doi: 10.18632/oncotarget.3188.
8
Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice.
Carcinogenesis. 2012 Apr;33(4):895-901. doi: 10.1093/carcin/bgs017. Epub 2012 Jan 20.
9
Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen.
Cell Prolif. 1999 Oct;32(5):289-302. doi: 10.1046/j.1365-2184.1999.3250289.x.
10
4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro.
Breast Cancer Res Treat. 1994;30(2):159-65. doi: 10.1007/BF00666060.
本文引用的文献
1
High-affinity anti-oestrogen binding site distinct from the oestrogen receptor.
Nature. 1980 Nov 20;288(5788):273-5. doi: 10.1038/288273a0.
2
Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells.
J Biol Chem. 1981 May 25;256(10):5016-21.
3
The binding of tamoxifen to human mammary carcinoma cytosol.
Eur J Cancer (1965). 1980 Sep;16(9):1141-8. doi: 10.1016/0014-2964(80)90172-3.
4
Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.
Cell. 1982 Mar;28(3):633-42. doi: 10.1016/0092-8674(82)90218-5.
5
Therapeutic effect of tamoxifen related to estrogen receptor level.
Recent Results Cancer Res. 1980;71:134-41. doi: 10.1007/978-3-642-81406-8_19.
6
Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase.
Cancer Res. 1983 Aug;43(8):3583-5.
7
Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines.
Cancer Res. 1983 Jul;43(7):3094-100.
8
Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards.
Cytometry. 1983 Mar;3(5):328-31. doi: 10.1002/cyto.990030504.
9
Long-term storage of samples for flow cytometric DNA analysis.
Cytometry. 1983 Mar;3(5):317-22. doi: 10.1002/cyto.990030502.
10
Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle.
Eur J Cancer Clin Oncol. 1983 May;19(5):615-21. doi: 10.1016/0277-5379(83)90177-3.
Zotero 插件